Ono Pharmaceutical Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	56,866	59,328	163,734	143,532	105,025	100,890
Depreciation & Amortization	36,449	26,894	18,140	17,451	17,721	15,820
Loss (Gain) From Sale of Assets	4,471	7,981	14,885	1,498	3,404	2,307
Other Operating Activities	-26,681	-45,211	-57,338	-6,655	-34,284	-34,057
Change in Accounts Receivable	-1,185	7,391	-19,782	-14,513	-15,283	-7,179
Change in Inventory	18,040	12,435	-3,420	-2,945	-2,464	-6,107
Change in Accounts Payable	8,338	18,786	-5,734	18,654	8,177	6,361
Change in Other Net Operating Assets	6,002	-5,145	175	2,588	-20,467	-4,058
Operating Cash Flow	102,300	82,459	110,660	159,610	61,829	73,977
Operating Cash Flow Growth	-5.85%	-25.48%	-30.67%	158.15%	-16.42%	-0.24%
Capital Expenditures	-6,535	-5,431	-4,020	-5,340	-5,497	-7,018
Sale of Property, Plant & Equipment	10	9	903	6	14	2
Cash Acquisitions	-	-364,816	-	-	-	-
Sale (Purchase) of Intangibles	-46,704	-2,559	-16,809	-9,157	-6,780	-13,275
Investment in Securities	36,712	236,764	69,290	-84,731	19,969	-36,866
Other Investing Activities	-1,155	-752	-1,287	-1,037	-1,668	-429
Investing Cash Flow	-17,672	-136,785	48,077	-100,259	6,038	-57,586
Long-Term Debt Issued	-	150,000	-	-	-	-
Total Debt Issued	-	150,000	-	-	-	-
Long-Term Debt Repaid	-	-15,000	-	-	-	-
Total Debt Repaid	-30,000	-15,000	-	-	-	-
Net Debt Issued (Repaid)	-30,000	135,000	-	-	-	-
Repurchase of Common Stock	-1	-1	-50,010	-1	-30,007	-3
Common Dividends Paid	-37,527	-37,516	-37,183	-29,742	-27,666	-22,449
Other Financing Activities	-3,321	-3,184	-2,655	-2,741	-2,564	-2,302
Financing Cash Flow	-70,849	94,299	-89,848	-32,484	-60,237	-24,754
Foreign Exchange Rate Adjustments	1,190	-1,548	1,116	155	436	403
Miscellaneous Cash Flow Adjustments	1	1	-	1	1	-
Net Cash Flow	14,970	38,426	70,005	27,023	8,067	-7,960
Free Cash Flow	95,765	77,028	106,640	154,270	56,332	66,959
Free Cash Flow Growth	-8.22%	-27.77%	-30.87%	173.86%	-15.87%	0.41%
Free Cash Flow Margin	19.01%	15.82%	21.21%	34.50%	15.59%	21.65%
Free Cash Flow Per Share	203.81	163.97	222.15	315.90	113.45	134.13
Cash Interest Paid	2,221	1,408	92	74	70	73
Cash Income Tax Paid	25,865	44,060	56,431	6,637	34,293	34,060
Levered Free Cash Flow	21,387	71,819	79,783	116,639	18,091	31,716
Unlevered Free Cash Flow	21,387	72,725	79,861	116,694	18,143	31,782
Change in Working Capital	31,195	33,467	-28,761	3,784	-30,037	-10,983

Source: S&P Global Market Intelligence. Standard template. Financial Sources.